mTOR Inhibition and Clinical Transplantation: Kidney

Transplantation. 2018 Feb;102(2S Suppl 1):S17-S18. doi: 10.1097/TP.0000000000001692.
No abstract available

Publication types

  • Review

MeSH terms

  • Calcineurin Inhibitors / adverse effects
  • Everolimus / therapeutic use*
  • Graft Rejection / prevention & control*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation*
  • Protein Kinase Inhibitors / therapeutic use*
  • Sirolimus / therapeutic use*
  • TOR Serine-Threonine Kinases / antagonists & inhibitors*

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Protein Kinase Inhibitors
  • Everolimus
  • MTOR protein, human
  • TOR Serine-Threonine Kinases
  • Sirolimus